OPTN (Option Therapeutics) OCF Margin %: 0.00% (As of Dec. 2025)


What is Option Therapeutics OCF Margin %?

Option Therapeutics OPTN OCF Margin % is 0.00% as of Dec. 2025.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Option Therapeutics's Cash Flow from Operations for the three months ended in Dec. 2025 was $-0.28 Mil. Option Therapeutics's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Option Therapeutics's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Option Therapeutics's current OCF Yield % is 0.00%.

The historical rank and industry rank for Option Therapeutics's OCF Margin % or its related term are showing as below:


OPTN's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.


Option Therapeutics OCF Margin % Related Terms


Option Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics OCF Margin % Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
OCF Margin %
0.00 0.00

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Option Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Option Therapeutics's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.157/0
= %

Option Therapeutics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.28/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Option Therapeutics (OPTN) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' OCF Margin % too high?
Option Therapeutics' current OCF Margin % is 0.00%.
How does Option Therapeutics' OCF Margin % compare to ?
Option Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.